Resources
37 Results (showing 1 - 10)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 7/31/2023 (updated 3/26/2024)
At the end of July 2023, the U.S. Food and Drug Administration approved a second over-the-counter naloxone nasal spray product, RiVive. The agency who received the approval to manufacture the product, Harm Reduction Therapeutics, does not yet have a timeline of availability and decision on pricing.
Posted 3/9/2022 (updated 3/27/2024)
IMPORTANCE Thousands of pregnant people with opioid use disorder (OUD) enter US jails annually,
yet their access to medications for OUD (MOUD) that meet the standard of care (methadone and/or
buprenorphine) is unknown.
OBJECTIVE To assess the availability of MOUD for the treatment of pregnant individuals with OUD
in US jails.
Posted 3/22/2022 (updated 3/27/2024)
Yesterday, the Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), is announcing two grant programs totaling $25.6 million that will expand access to medication-assisted treatment for opioid use disorder and prevent the misuse of prescription drugs. By reducing barriers to accessing the most effective, evidenced-based treatments, this funding reflects the priorities of HHS' Overdose Prevention Strategy, as well as its new initiative to strengthen the nation's mental health and crisis care systems.
Posted 3/9/2022 (updated 3/27/2024)
The U.S. Department of Health and Human Services (HHS) together with leading clinicians, researchers, and policy experts led the development of a standard clinical definition for opioid withdrawal in infants to help improve care. It is accompanied with a set of foundational principles that outlines bioethical uses for the definition, distinctly centering around identifying clinical and supportive care needs of mothers and their infants, using an evidence-based, compassionate, and equitable approach.
Posted 6/14/2022 (updated 3/27/2024)
On Wednesday, the U.S. Department of Health & Human Services announced nearly $15 million awarded to rural communities to continue addressing misuse of illegal and prescription drugs known as psychostimulants. These awards are part of the Rural Communities Opioid Response Program (RCORP), a multi-year initiative with $400 million invested since its start in 2018.
Posted 6/27/2022 (updated 3/27/2024)
The U.S. Department of Housing and Urban Development (HUD) announced a broad, new initiative to connect individuals and families to housing, health care, and supportive services. Total funding of $322 million is a supplement to HUD’s Continuum of Care (CoC) Program, with $43 million for incremental housing vouchers for at-risk households, and $54 million set aside for projects in rural areas.
Posted 9/25/2023 (updated 3/27/2024)
The U.S. Department of Health and Human Services (HHS) has now added American Sign Language (ASL) services to the 988 Suicide and Crisis Lifeline. An ongoing effort of the HHS is to expand accessibility to behavioral health care for underserved communities, which includes individuals who are Deaf and Hard of Hearing.
Posted 7/20/2022 (updated 3/27/2024)
Last week, the Centers for Medicare & Medicaid Services (CMS) Office of Minority Health released the CMS Framework for Health Equity. Using five priority areas, CMS will use this framework to design, implement, and operationalize policies and programs to support health for all people served by its programs including rural populations.
Posted 5/3/2022 (updated 3/27/2024)
During Second Chance Month, the Biden-Harris Administration is releasing a comprehensive strategy that expands Incarceration to Employment opportunities, as well as the following concrete policy actions as part of a whole-of-government effort to advance employment, bolster reentry, empower formerly incarcerated persons, and strengthen our communities and our economy.
Posted 5/24/2022 (updated 3/27/2024)
These contingency management resources include a statement and advisory opinions from the United States Department of Health and Human Services Office of Inspector General. Additionally, the Contingency Management factsheet provides an overview of the approach.